<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ULESFIA- benzyl alcoholÂ lotionÂ </strong><br>Concordia Pharmaceuticals Inc.<br></p></div>
<div id="Highlights" class="Highlights"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1>HIGHLIGHTS OF PRESCRIBING INFORMATION</h1>
<div class="HighlightsDisclaimer">
<span class="Bold">These highlights do not include all the information needed to use</span><span class="Bold">Â </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"> safely and effectively. </span><span class="Bold">Â </span><span class="Bold">See full prescribing information for </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">.</span><br><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">(benzyl alcohol)</span><span class="Bold">Â </span><span class="Bold">l</span><span class="Bold">otion</span><span class="Bold">, f</span><span class="Bold">or topical use</span><br><span class="Bold">Initial U.S. Approval:</span><span class="Bold">Â </span><span class="Bold"> 200</span><span class="Bold">9</span><br>
</div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>INDICATIONS AND USAGE</span></h1>
<div>
<p class="Highlighta">ULESFIA<span class="Sup">Â®</span>Â LotionÂ is a pediculicide indicated for the topical treatment of <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span> in patients 6 months of age and older. (<a href="#_1_1__">1.1</a>) </p>
<p class="Highlighta">ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion does not have ovocidal activity. (<a href="#_1_2__">1.2</a>) </p>
</div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE AND ADMINISTRATION</span></h1>
<div>
<ul class="Disc">
<li>Apply ULESFIA<span class="Sup">Â®</span>Â LotionÂ to <span class="product-label-link" type="condition" conceptid="4194803" conceptname="Dry hair">dry hair</span>, using enough to completely saturate the scalp and hair. (<a href="#_2__">2</a>)Â <br>
</li>
<li>Rinse off with water after 10 minutes. (<a href="#_2__">2</a>)<br>
</li>
<li>Repeat application in 7 days. (<a href="#_2__">2</a>)</li>
</ul>
<table>
<caption><span>Table 1: ULESFIA<span class="Sup">Â®</span>Â Lotion Usage Guideline</span></caption>
<col>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="center" colspan="2" valign="bottom">Hair Length</td>
<td class="Lrule Rrule Toprule" align="center" colspan="2">Amount of<br>ULESFIA<span class="Sup">Â®</span> Lotion<br>per Application</td>
</tr>
<tr>
<td class="Lrule Rrule" align="center" colspan="2"></td>
<td class="Lrule Rrule Toprule" align="center"><span class="Bold">Ounces</span></td>
<td class="Lrule Rrule Toprule" align="center"><span class="Bold">8 oz bottle</span></td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Short</td>
<td class="Lrule Rrule Toprule" align="right">0-2 inches</td>
<td class="Lrule Rrule Toprule" align="right">4-6 oz </td>
<td class="Lrule Rrule Toprule" align="center">Â½-Â¾ bottle</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">2-4 inches</td>
<td class="Lrule Rrule Toprule" align="right">6-8 oz </td>
<td class="Lrule Rrule Toprule" align="center">Â¾-1 bottle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Medium</td>
<td class="Lrule Rrule Toprule" align="right">4-8 inches</td>
<td class="Lrule Rrule Toprule" align="right">8-12 oz </td>
<td class="Lrule Rrule Toprule" align="center">1-1Â½ bottles</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">8-16 inches</td>
<td class="Lrule Rrule Toprule" align="right">12-24 oz </td>
<td class="Lrule Rrule Toprule" align="center">1Â½-3 bottles</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Long</td>
<td class="Lrule Rrule Toprule" align="right">16-22 inches</td>
<td class="Lrule Rrule Toprule" align="right">24-32 oz </td>
<td class="Lrule Rrule Toprule" align="center">3-4 bottles</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">Over 22 inches</td>
<td class="Lrule Rrule Toprule" align="right">32-48 oz </td>
<td class="Lrule Rrule Toprule" align="center">4-6 bottles</td>
</tr>
</tbody>
</table>
</div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE FORMS AND STRENGTHS</span></h1>
<div><p class="Highlighta">Lotion,Â 5% (<a href="#_3__">3</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>CONTRAINDICATIONS</span></h1>
<div><p class="Highlighta">None. (<a href="#_4__">4</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>WARNINGS AND PRECAUTIONS</span></h1>
<div><ul class="Disc">
<li>Neonatal toxicity: Risk of <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome if benzyl alcohol is used in neonates. (<a href="#_5_1__">5.1</a>)<br>
</li>
<li><span class="product-label-link" type="condition" conceptid="4049206" conceptname="Burning sensation in eye">Eye irritation</span>: Avoid eye exposure.  Flush immediately with water if ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion comes into contact with eyes. (<a href="#_5_2__">5.2</a>)<br>
</li>
<li><span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">Contact dermatitis</span>: May occur with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion. (<a href="#_5_3__">5.3</a>)<br>
</li>
<li>Use in children: ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion should only be used on children under the direct supervision of an adult.  Keep out of reach of children. (<a href="#_5_4__">5.4</a>)</li>
</ul></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>ADVERSE REACTIONS</span></h1>
<div>
<p class="Highlighta">Most common adverse reactions (&gt; 1% and more common than with placebo): ocular irritation, <span class="product-label-link" type="condition" conceptid="4318383" conceptname="Application site irritation">application site irritation</span>, and <span class="product-label-link" type="condition" conceptid="4317271" conceptname="Application site anesthesia">application site anesthesia</span> and <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">hypoesthesia</span>. (<a href="#_6__">6</a>)  </p>
<p class="Highlighta"><span class="Bold"><br><br>To report SUSPECTED ADVERSE REACTIONS, contact Concordia Pharmaceuticals Inc. at 1-877-370-1142 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</span> </p>
</div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DRUG INTERACTIONS</span></h1>
<div><p class="Highlighta">Drug interaction studies were not conducted. (<a href="#_7__">7</a>) </p></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>USE IN SPECIFIC POPULATIONS</span></h1>
<div>
<p class="Highlighta">Pediatric Use: Safety in pediatric patients under six months of age has not been established. (<a href="#_8_4__">8.4</a>) </p>
<p class="Highlighta">
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	 </p>
</div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
<div>
<div></div>
<div></div>
</div>
<div><div></div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<p class="HighlightsSeeReference">See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.</p>
<p class="HighlightsRevision">Revised: 1/2014</p>
</div></td></tr></table></div>
<div id="Index" class="Index"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1 class="Colspan">FULL PRESCRIBING INFORMATION: CONTENTS<a href="#footnote-content" name="footnote-reference-content">*</a>
</h1>
<h1><a href="#section-1" class="toc"><span class="Bold">1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">INDICATIONS AND USAGE</span></a></h1>
<h2><a href="#section-1.1" class="toc"><span class="Bold">1.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Indication</span></a></h2>
<h2><a href="#section-1.2" class="toc"><span class="Bold">1.2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Limitation of Use</span></a></h2>
<h2><a href="#section-1.3" class="toc"><span class="Bold">1.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Adjunctive Measures</span></a></h2>
<h1><a href="#section-2" class="toc"><span class="Bold">2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DOSAGE AND ADMINISTRATION</span></a></h1>
<h1><a href="#section-3" class="toc"><span class="Bold">3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DOSAGE FORM</span><span class="Bold">S</span><span class="Bold"> AND STRENGTH</span><span class="Bold">S</span></a></h1>
<h1><a href="#section-4" class="toc"><span class="Bold">4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CONTRAINDICATIONS</span></a></h1>
<h1><a href="#section-5" class="toc"><span class="Bold">5</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">WARNINGS AND PRECAUTIONS</span></a></h1>
<h2><a href="#section-5.1" class="toc"><span class="Bold">5.</span><span class="Bold">1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Neonatal Toxicity</span></a></h2>
<h2><a href="#section-5.2" class="toc"><span class="Bold">5.2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold"><span class="product-label-link" type="condition" conceptid="4049206" conceptname="Burning sensation in eye">Eye Irritation</span></span><span class="Bold">Â </span></a></h2>
<h2><a href="#section-5.3" class="toc"><span class="Bold">5.</span><span class="Bold">3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Contact Derm</span><span class="Bold">a</span><span class="Bold">titis</span></a></h2>
<h2><a href="#section-5.4" class="toc"><span class="Bold">5.4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Use in Children</span><span class="Bold">Â </span></a></h2>
<h1><a href="#section-6" class="toc"><span class="Bold">6</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">ADVERSE REACTIONS</span></a></h1>
<h2><a href="#section-6.1" class="toc"><span class="Bold">6.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Clinical </span><span class="Bold">Trials </span><span class="Bold">Experience</span></a></h2>
<h1><a href="#section-7" class="toc"><span class="Bold">7</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DRUG INTERACTIONS</span></a></h1>
<h1><a href="#section-8" class="toc"><span class="Bold">8</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">USE IN SPECIFIC POPULATIONS</span></a></h1>
<h2><a href="#section-8.1" class="toc"><span class="Bold">8.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pregnancy</span></a></h2>
<h2><a href="#section-8.2" class="toc"><span class="Bold">8.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Nursing Mothers</span></a></h2>
<h2><a href="#section-8.3" class="toc"><span class="Bold">8.4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pediatric Use</span></a></h2>
<h2><a href="#section-8.4" class="toc"><span class="Bold">8.5</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Geriatric Use</span></a></h2>
<h1><a href="#section-9" class="toc"><span class="Bold">10</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">OVERDOSAGE</span></a></h1>
<h1><a href="#section-10" class="toc"><span class="Bold">11</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DESCRIPTION</span></a></h1>
<h1><a href="#section-11" class="toc"><span class="Bold">12</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CLINICAL PHARMACOLOGY</span></a></h1>
<h2><a href="#section-11.1" class="toc"><span class="Bold">12.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Mechanism of Action</span></a></h2>
<h2><a href="#section-11.2" class="toc"><span class="Bold">12.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pharmacokinetics</span></a></h2>
<h1><a href="#section-12" class="toc"><span class="Bold">13</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">NONCLINICAL TOXICOLOGY</span></a></h1>
<h2><a href="#section-12.1" class="toc"><span class="Bold">13.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Carcinogenesis, Mutagenesis, Impairment of F</span><span class="Bold">ertility</span><span class="Bold">Â </span></a></h2>
<h1><a href="#section-13" class="toc"><span class="Bold">14</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CLINICAL STUDIES</span></a></h1>
<h1><a href="#section-14" class="toc"><span class="Bold">16</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">HOW SUPPLIED/STORAGE AND HANDLING</span></a></h1>
<h1><a href="#section-15" class="toc"><span class="Bold">17</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">PATIENT COUNSELING INFORMATION</span></a></h1>
<dl class="Footnote">
<dt><a href="#footnote-reference-content" name="footnote-content">*</a></dt>
<dd>Sections or subsections omitted from the full prescribing information are not listed.</dd>
</dl>
</div></td></tr></table></div>
<div class="Contents">
<h1>FULL PRESCRIBING INFORMATION</h1>
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-1"></a><p></p>
<h1>
<span class="Bold">1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">INDICATIONS AND USAGE</span>
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="_1_1__"></a><a name="section-1.1"></a><p></p>
<h2>
<span class="Bold">1.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Indication</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is indicated for the topical treatment of <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span> in patients 6 months of age and older.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="_1_2__"></a><a name="section-1.2"></a><p></p>
<h2>
<span class="Bold">1.2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Limitation of Use</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Â ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion does not have ovocidal activity.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1.3"></a><p></p>
<h2>
<span class="Bold">1.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Adjunctive Measures</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion should be used in the context of an overall lice management program:</p>
<ul class="Square">
<li>Wash (in hot water) or dry-clean all recently worn clothing, hats, used bedding, and towels.<br>
</li>
<li>Wash personal care items such as combs, brushes and hair clips in hot water.Â Â <br>
</li>
<li>A fine-tooth comb or special nit comb may be used to remove dead lice and nits.</li>
</ul>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="_2__"></a><a name="section-2"></a><p></p>
<h1>
<span class="Bold">2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DOSAGE AND ADMINISTRATION</span>
</h1>
<p class="First">
		Â Â Â Â Â ULESFIA<span class="Sup">Â®</span>Â Lotion is not for oral, ophthalmic, or intravaginal use.
                  </p>
<p>
		Â Â Â Â Â Using the guidelines in Table 1, apply sufficient ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to <span class="product-label-link" type="condition" conceptid="4194803" conceptname="Dry hair">dry hair</span> to completely saturate the scalp and hair; leave on for 10 minutes, then thoroughly rinse off with water.  Repeat application after 7 days.  Avoid contact with eyes.              </p>
<table>
<caption><span>Table 1: ULESFIA<span class="Sup">Â®</span>Â Lotion Usage Guideline</span></caption>
<col width="51">
<col width="117">
<col width="80">
<col width="90">
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="center" colspan="2" valign="bottom">Hair Length</td>
<td class="Lrule Rrule Toprule" align="center" colspan="2">Amount of<br>ULESFIA<span class="Sup">Â®</span> Lotion<br>per Application</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left" colspan="2"><span class="XmChange">Â Â </span></td>
<td class="Lrule Rrule Toprule" align="right"><span class="Bold">Ounces</span></td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">8 oz bottle</span><span class="Bold"> Size</span>
</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Short</td>
<td class="Lrule Rrule Toprule" align="right">0-2 inches</td>
<td class="Lrule Rrule Toprule" align="right">4-6 ozÂ </td>
<td class="Lrule Rrule Toprule" align="center">Â½-Â¾ bottle</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">2-4 inches</td>
<td class="Lrule Rrule Toprule" align="right">6-8 oz </td>
<td class="Lrule Rrule Toprule" align="center">Â¾-1 bottle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Medium</td>
<td class="Lrule Rrule Toprule" align="right">4-8 inches</td>
<td class="Lrule Rrule Toprule" align="right">8-12 oz </td>
<td class="Lrule Rrule Toprule" align="center">1-1Â½ bottles</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">8-16 inches</td>
<td class="Lrule Rrule Toprule" align="right">12-24 oz </td>
<td class="Lrule Rrule Toprule" align="center">1Â½-3 bottles</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Long</td>
<td class="Lrule Rrule Toprule" align="right">16-22 inches</td>
<td class="Lrule Rrule Toprule" align="right">24-32 ozÂ </td>
<td class="Lrule Rrule Toprule" align="center">3-4 bottles</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="right">Over 22 inches</td>
<td class="Lrule Rrule Toprule" align="right">32-48 ozÂ </td>
<td class="Lrule Rrule Toprule" align="center">4-6 bottles</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="43678-2">
<a name="_3__"></a><a name="section-3"></a><p></p>
<h1>
<span class="Bold">3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DOSAGE FORM</span><span class="Bold">S</span><span class="Bold"> AND STRENGTH</span><span class="Bold">S</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Sup">Â®</span>Â Lotion is a white topical lotion containingÂ benzyl alcohol, 5% (50 mg/g of lotion).Â </p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="_4__"></a><a name="section-4"></a><p></p>
<h1>
<span class="Bold">4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CONTRAINDICATIONS</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	None.</p>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="_5__"></a><a name="section-5"></a><p></p>
<h1>
<span class="Bold">5</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">WARNINGS AND PRECAUTIONS</span>
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="_5_1__"></a><a name="section-5.1"></a><p></p>
<h2>
<span class="Bold">5.</span><span class="Bold">1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Neonatal Toxicity</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Intravenous administration of products containing benzyl alcohol has been associated with neonatal <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome consisting of severe <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> respirations, progressive <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, central nervous system <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="443752" conceptname="Ventricular hemorrhage">intraventricular hemorrhage</span>, and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> in preterm, low birth weight infants. Neonates (i.e. patients less than 1Â month of age or preterm infants with a corrected age of less than 44 weeks) could be at risk for <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome if treated with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â LotionÂ <span class="Italics">[see </span><span class="Italics"><a href="#_8__">Use in Specific Populations</a></span><span class="Italics"> (</span><span class="Italics"><a href="#_8_4__">8.4</a></span><span class="Italics">)]</span>.Â Â </p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="_5_2__"></a><a name="section-5.2"></a><p></p>
<h2>
<span class="Bold">5.2</span><span class="Bold">Â Â Â Â Â </span><span class="Bold"><span class="product-label-link" type="condition" conceptid="4049206" conceptname="Burning sensation in eye">Eye Irritation</span></span><span class="Bold">Â </span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Avoid eye exposure.  ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion may cause <span class="product-label-link" type="condition" conceptid="4049206" conceptname="Burning sensation in eye">eye irritation</span>.  If ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion comes in contact with the eyes, flush them immediately with water.  If irritation persists, consult a physician.</p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="_5_3__"></a><a name="section-5.3"></a><p></p>
<h2>
<span class="Bold">5.</span><span class="Bold">3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Contact Derm</span><span class="Bold">a</span><span class="Bold">titis</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion may cause allergic or irritant <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>.</p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="_5_4__"></a><a name="section-5.4"></a><p></p>
<h2>
<span class="Bold">5.4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Use in Children</span><span class="Bold">Â </span>
</h2>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion should only be used on children (6 months of age and older) under the direct supervision of an adult.  Keep out of reach of children. </p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="_6__"></a><a name="section-6"></a><p></p>
<h1>
<span class="Bold">6</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">ADVERSE REACTIONS</span>
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.1"></a><p></p>
<h2>
<span class="Bold">6.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Clinical </span><span class="Bold">Trials </span><span class="Bold">Experience</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.</p>
<p>
		Â Â Â Â Â 
	The rates of adverse reactions below were derived from two randomized, multi-center, vehicle-controlled clinical trials and one open-label study in subjects with <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span>.  </p>
<p>
		Â Â Â Â Â 
	Skin, scalp, and ocular irritation were monitored in the clinical trials.  All subjects were queried about the presence of skin and scalp symptoms; the results are presented in Table 2. </p>
<p>Â </p>
<table>
<caption><span>
		Â Â Â Â Â 
	Table 2: Monitored Adverse Reactions - Application Site Symptoms</span></caption>
<col width="121">
<col width="100">
<col width="92">
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="center">Event</td>
<td class="Lrule Rrule Toprule" align="center">ULESFIA<span class="Bold"><span class="Sup">Â®</span></span><br>Lotion</td>
<td class="Lrule Rrule Toprule" align="center">Vehicle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Application site <br>Irritation</td>
<td class="Lrule Rrule Toprule" align="left">2% (11/478)</td>
<td class="Lrule Rrule Toprule" align="left">1% (2/336)</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Application site <br>anesthesia &amp;<br><span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">hypoesthesia</span></td>
<td class="Lrule Rrule Toprule" align="left">2% (10/478)</td>
<td class="Lrule Rrule Toprule" align="left">0% (0/336)</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule Toprule" align="left"><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span></td>
<td class="Lrule Rrule Toprule" align="left">1% (5/478)</td>
<td class="Lrule Rrule Toprule" align="left">0% (1/336)</td>
</tr>
</tbody>
</table>
<p>
		Â Â Â Â Â 
	The subset of subjects who did not have <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> or pyodermaÂ of skin and scalp, orÂ ocular irritation prior to treatment were assessed for these signs and symptoms after treatment; the results are presented in Table 3.</p>
<p>
		Â Â Â Â Â 
	</p>
<table>
<caption><span>Table 3: Monitored Adverse Reactions - 
		Â Â Â Â Â 
	<span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">Erythema</span>, <span class="product-label-link" type="condition" conceptid="133547" conceptname="Pyoderma">Pyoderma</span> and Ocular Irritation with Onset After Treatment </span></caption>
<col width="153">
<col width="130">
<col width="120">
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="center">Signs/Symptoms<br>
</td>
<td class="Lrule Rrule Toprule" align="center">ULESFIA<span class="Bold"><span class="Sup">Â®</span></span><br>Lotion</td>
<td class="Lrule Rrule Toprule" align="center">Vehicle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left"><span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span></td>
<td class="Lrule Rrule Toprule" align="right">12% (14/116)</td>
<td class="Lrule Rrule Toprule" align="right">4% (3/67)</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left"><span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">Erythema</span></td>
<td class="Lrule Rrule Toprule" align="right">10% (32/309)</td>
<td class="Lrule Rrule Toprule" align="right">9% (19/217)</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left"><span class="product-label-link" type="condition" conceptid="133547" conceptname="Pyoderma">Pyoderma</span></td>
<td class="Lrule Rrule Toprule" align="right">7% (22/308)</td>
<td class="Lrule Rrule Toprule" align="right">4% (10/230)</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule Toprule" align="left">Ocular irritation</td>
<td class="Lrule Rrule Toprule" align="right">6% (26/428)</td>
<td class="Lrule Rrule Toprule" align="right">1% (3/313)</td>
</tr>
</tbody>
</table>
<p>
		Â Â Â Â Â 
	Other less common reactions (less than 1% but more thanÂ 0.1%) were, in decreasing order of incidence: application site dryness, application site <span class="product-label-link" type="condition" conceptid="4219876" conceptname="Excoriation">excoriation</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paraesthesia</span>, <span class="product-label-link" type="condition" conceptid="4319313" conceptname="Application site rash">application site dermatitis</span>, <span class="product-label-link" type="condition" conceptid="4219876" conceptname="Excoriation">excoriation</span>, <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">thermal burn</span>, <span class="product-label-link" type="condition" conceptid="4308080" conceptname="Pityriasis simplex">dandruff</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">skin exfoliation</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="_7__"></a><a name="section-7"></a><p></p>
<h1>
<span class="Bold">7</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DRUG INTERACTIONS</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	Drug interaction studies were not conducted withÂ ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</p>
</div>
<div class="Section" data-sectionCode="43684-0">
<a name="_8__"></a><a name="section-8"></a><p></p>
<h1>
<span class="Bold">8</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">USE IN SPECIFIC POPULATIONS</span>
</h1>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.1"></a><p></p>
<h2>
<span class="Bold">8.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pregnancy</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Pregnancy Category B</p>
<p>
		Â Â Â Â Â 
	There are no adequate and well-controlled studies with topical benzyl alcohol in pregnant women.  Reproduction studies conducted in rats and rabbits were negative.  Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
<p>
		Â Â Â Â Â 
	No comparisons of animal exposure with human exposure are provided in this labeling due to the low systemic exposure noted in the clinical pharmacokinetic study <span class="Italics">[see </span><span class="Italics"><a href="#_12__">Clinical Pharmacology</a></span><span class="Italics"> (</span><span class="Italics"><a href="#_12_3__">12.3</a></span><span class="Italics">)]</span> which did not allow for the determination of human AUC values that could be used for this calculation.</p>
<p>
		Â Â Â Â Â 
	Pregnant rats were dosed with benzyl alcohol via subcutaneous injection at 100, 250, and 500 mg/kg/day.  No teratogenic effects were noted at any dose.  Maternal toxicity and decreased fetal weight occurred at 500 mg/kg/day.  When pregnant rabbits received subcutaneous injections of benzyl alcohol at 100, 250, and 400 mg/kg/day, there were no teratogenic effects in offspring at any dose.  In rabbits, maternal toxicity occurred at the two higher doses and was associated with decreased fetal weight at the highest dose. </p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-8.2"></a><p></p>
<h2>
<span class="Bold">8.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Nursing Mothers</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	It is not known whether benzyl alcohol is excreted into human milk.  Because some systemic absorption of topical benzyl alcohol may occur and because many drugs are excreted in human milk, caution should be exercised when ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â LotionÂ is administered to a nursing woman.</p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="_8_4__"></a><a name="section-8.3"></a><p></p>
<h2>
<span class="Bold">8.4</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pediatric Use</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	The safety and effectiveness of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion was evaluated in two multicenter, randomized, double-blind, vehicle-controlled studies which were conducted in 628 subjects 6 months of age and older with active <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span> <span class="Italics">[see </span><span class="Italics"><a href="#_14__">Clinical Studies</a></span><span class="Italics"> (</span><span class="Italics"><a href="#_14__">14</a></span><span class="Italics">)]</span>.</p>
<p>
		Â Â Â Â Â 
	Rates of adverse events in younger children (6 months to 12 years) were similar to those of older children and adults. </p>
<p>
		Â Â Â Â Â 
	Safety in pediatric patients below the age of 6 months has not been established.  ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is not recommended in pediatric patients under six months of age because of the potential for increased systemic absorption due to a high ratio of skin surface area to body <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span> and the potential for an immature skin barrier. </p>
<p>
		Â Â Â Â Â 
	Neonates could be at risk for <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome if treated with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â LotionÂ <span class="Italics">[s</span><span class="Italics">ee </span><span class="Italics"><a href="#_5__">Warnings and Precautions</a></span><span class="Italics">Â </span><span class="Italics">(</span><span class="Italics"><a href="#_5_1__">5.1</a></span><span class="Italics">)]</span><span class="Italics">.</span></p>
<p>
		Â Â Â Â Â 
	Intravenous administration of products containing benzyl alcohol has been associated with neonatal <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome. Â The <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome (characterized by central nervous <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> respirations, and high levels of benzyl alcohol and its metabolites found in the blood and urine) has been associated with benzyl alcohol dosages &gt; 99 mg/kg/day in preterm neonates.Â  Additional symptoms may include gradual neurological deterioration, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>, <span class="product-label-link" type="condition" conceptid="439847" conceptname="Intracranial hemorrhage">intracranial hemorrhage</span>, hemotologic abnormalities, <span class="product-label-link" type="condition" conceptid="140842" conceptname="Changes in skin texture">skin breakdown</span>, hepatic and <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal failure</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, and <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span>.Â  Although expected systemic exposure of benzyl alcohol from proper use of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is substantially lower than those reported in association with the <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">gasping</span> syndrome, the minimum amount of benzyl alcohol at which toxicity may occur is not known.</p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="section-8.4"></a><p></p>
<h2>
<span class="Bold">8.5</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Geriatric Use</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	The safety of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion in patients over 60 years of age has not been established. </p>
<p>
		Â Â Â Â Â 
	</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>
<span class="Bold">10</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">OVERDOSAGE</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	If oral ingestion occurs, seek medical advice immediately.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-10"></a><p></p>
<h1>
<span class="Bold">11</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">DESCRIPTION</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â (benzyl alcohol) Lotion is supplied as a white topical lotion containing benzyl alcohol, 5%.  Inactive ingredients in this formulation are water, mineral oil, sorbitan monooleate, polysorbate 80, carbomer 934P and trolamine.</p>
<p>
		Â Â Â Â Â 
	The active ingredient, benzyl alcohol, is a clear, colorless liquid with a mild aromatic odor.Â Â Benzyl alcohol has a molecular <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span> of 108.14 g/mol.  The molecular formula is C<span class="Sub">7</span>H<span class="Sub">8</span>O.  </p>
<p>
		Â Â Â Â Â 
	The chemical structure of benzyl alcohol is:</p>
<p>
		Â Â Â Â Â 
	</p>
<div class="Figure">
<img alt="Chemical structure of benzyl alcohol " src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-01.jpg"><p class="MultiMediaCaption">Benzyl Alcohol</p>
</div>
<p>.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="_12__"></a><a name="section-11"></a><p></p>
<h1>
<span class="Bold">12</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CLINICAL PHARMACOLOGY</span>
</h1>
<div class="Section" data-sectionCode="43679-0">
<a name="section-11.1"></a><p></p>
<h2>
<span class="Bold">12.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Mechanism of Action</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	<span class="Italics">In vitro</span> studies of the effect ofÂ ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion on native, captured lice suggest that benzyl alcohol inhibits lice from closing their respiratory spiracles, allowing the vehicle to obstruct the spiracles and causing the lice to asphyxiate.</p>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="_12_3__"></a><a name="section-11.2"></a><p></p>
<h2>
<span class="Bold">12.3</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Pharmacokinetics</span>
</h2>
<p class="First">
		Â Â Â Â Â 
	The absorption of benzyl alcohol fromÂ ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion was evaluated in 19 subjects with <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span>. Subjects were divided into two age groups: 6 months to 3 years and 4 to 11 years. Â ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â LotionÂ was applied for an exaggerated exposure period (3 times the normal exposure period).  Benzyl alcohol was quantified in a single plasma sample inÂ 4 out of 19 subjectsÂ (21%): three subjects in the 6 months to 3 years age group at 0.5 hour post-treatment (ranging from 1.97 to 2.99 mcg/mL) and one subject in the 4 to 11 year age group (1.63 mcg/mL)Â at 1 hour post-treatment out of a total of 102 samples analyzed.</p>
</div>
</div>
<div class="Section" data-sectionCode="43680-8">
<a name="section-12"></a><p></p>
<h1>
<span class="Bold">13</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">NONCLINICAL TOXICOLOGY</span>
</h1>
<div class="Section" data-sectionCode="34083-6">
<a name="section-12.1"></a><p></p>
<h2>
<span class="Bold">13.1</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">Carcinogenesis, Mutagenesis, Impairment of F</span><span class="Bold">ertility</span><span class="Bold">Â </span>
</h2>
<p class="First">
		Â Â Â Â Â 
	Long-term studies in animals to evaluate carcinogenic potential of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion have not been conducted.  No evidence of carcinogenic activity was noted for benzyl alcohol in 2 year oral carcinogenicity studies in rats (doses up to 400 mg/kg benzyl alcohol) or mice (doses up to 200 mg/kg benzyl alcohol) conducted by the National Toxicology Program.  </p>
<p>
		Â Â Â Â Â 
	Benzyl alcohol has produced mixed results in genetic testing.  Benzyl alcohol was negative in the Ames test with and without metabolic activation, sex-linked recessive lethal assay, and a replicative DNA synthesis assay (conducted in male rats).  Negative results were obtained in the mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> assay with metabolic activation, but a positive response was noted in the mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> assay without metabolic activation at a concentration producing a high level of cellular toxicity.  Benzyl alcohol was positive in the Chinese hamster ovary chromosomal aberration assay with metabolic activation.</p>
<p>
		Â Â Â Â Â 
	No fertility studies have been conducted with benzyl alcohol.Â </p>
<p>Â Â Â Â Â Â Â Â Â Â </p>
</div>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="_14__"></a><a name="section-13"></a><p></p>
<h1>
<span class="Bold">14</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">CLINICAL STUDIES</span>
</h1>
<p class="First">
		Â Â Â Â Â 
	Two multicenter, randomized, double-blind, vehicle-controlled studies were conducted in 628 subjects 6 months of age and older with active <span class="product-label-link" type="condition" conceptid="132835" conceptname="Pediculosis capitis">head lice</span> <span class="product-label-link" type="condition" conceptid="432251" conceptname="Disease caused by parasite">infestation</span>.  For the evaluation of efficacy, the youngest subject from each household was enrolled in the Primary Treatment Cohort with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion or vehicle.  Other infested household members were enrolled in a Secondary Treatment Cohort and received the same treatment as the youngest subjects.  The Secondary Treatment Cohort was not included in the efficacy analysis, but was evaluated for all safety parameters.</p>
<p>
		Â Â Â Â Â 
	In Study One, 125 Primary Treatment Cohort Subjects were randomized to ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion (N=63) and vehicle (N=62).  Study Two enrolled 125 Primary Treatment Cohort Subjects:Â 64 randomized to ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion and 61 to vehicle.  Treatment was applied two times separated by one week. </p>
<p>
		Â Â Â Â Â 
	Efficacy was assessed as the proportion of subjects who were free of live lice 14 days after the final treatment.  Subjects with live lice present at any time after first treatment were considered to be treatment failures.  Table 4 contains the proportion of subjects who were free of live lice in each of the two trials. </p>
<p>
		Â Â Â Â Â 
	</p>
<table>
<caption><span>Table 4: Proportion of Subjects Free of Live Lice 14 Days After Last Treatment</span></caption>
<col width="81">
<col width="144">
<col width="114">
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="left"></td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">LOTION</span>
</td>
<td class="Lrule Rrule Toprule" align="center"><span class="Bold">Vehicle</span></td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">
<span class="Bold">Study 1</span><br>
</td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">(</span><span class="Bold">N</span><span class="Bold">=63)</span><br><span class="Bold">48 (76.2%)</span>
</td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">(</span><span class="Bold">N</span><span class="Bold">=62)</span><br><span class="Bold">3 (4.8%</span><span class="Bold">)</span>
</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule Toprule" align="left">
<span class="Bold">Study 2</span><br>
</td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">(</span><span class="Bold">N</span><span class="Bold">=64)</span><br><span class="Bold">48 (75.0%)</span>
</td>
<td class="Lrule Rrule Toprule" align="center">
<span class="Bold">(</span><span class="Bold">N</span><span class="Bold">=61)</span><br><span class="Bold">16 (26.2%)</span>
</td>
</tr>
</tbody>
</table>
<p>
		Â Â Â Â Â 
	</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-14"></a><p></p>
<h1>
<span class="Bold">16</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">HOW SUPPLIED/STORAGE AND HANDLING</span>
</h1>
<p class="First">ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â LotionÂ is a white topical lotion containing benzyl alcohol, 5% (50 mg/g of lotion)Â <br>
		Â Â Â Â Â 
	â—?      NDC 59212-780-08 as an 8 fl oz (227 g) in a polypropylene bottle<br>
		Â Â Â Â Â 
	â—?      NDC 59212-780-88 as a package containing two individual 8 fl oz (NDC 59212-780-08) polypropylene bottles with a nit comb</p>
<p>
		Â Â Â Â Â 
	Store at 20Âº C - 25Âº C (68ÂºÂ F - 77Âº F); excursions permitted to 15Âº C - 30Âº C (59Âº F - 86Âº F) [See USP controlled room temperature].</p>
<p>
		Â Â Â Â Â 
	Do not freeze.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-15"></a><p></p>
<h1>
<span class="Bold">17</span><span class="Bold">Â Â Â Â Â </span><span class="Bold">PATIENT COUNSELING INFORMATION</span>
</h1>
<p class="First">â€œSee FDA-approved patient labeling (Patient Information)â€?</p>
<p>Inform the patient and caregiver of the following instructions:</p>
<ul class="Disc">
<li>Apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span> Lotion for 10 minutes as directed in the ULESFIA<span class="Bold"><span class="Sup">Â®</span></span> Lotion Usage Guideline Table.Â <br>
</li>
<li>Apply a second treatment 1 week (7 days) after the initial application.<br>
</li>
<li>Use only on <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry scalp</span> and <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry scalp</span> hair.  <br>
</li>
<li>Avoid contact with eyes.<br>
</li>
<li>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion may cause eyeÂ irritation, <span class="product-label-link" type="condition" conceptid="4280604" conceptname="Skin irritation">skin irritation</span>, and contactÂ sensitization.<br>
</li>
<li>Wash hands after application.<br>
</li>
<li>Report any signs of irritation at the application site and any signs of adverse reactions.<br>
</li>
<li>Keep out of reach of children.</li>
</ul>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="section-16"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Patient Information</span></p>
<p><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">(Yoo-Les-fee-ah</span><span class="Bold">)</span><br><span class="Bold">(benzyl alcohol 5%)</span><br><span class="Bold">Lotion</span></p>
<p>Read the Patient Information that comes with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion before you start using it and each time you get a refill.  There may be new information.  This leaflet does not take the place of talking to your healthcare provider about your medical condition or treatment. </p>
<table>
<col width="360">
<tbody class="Headless"><tr class="First Last"><td class="Lrule Rrule Toprule" align="left"><span class="Bold">Note: For use on scalp hair and scalp only</span></td></tr></tbody>
</table>
<p><span class="Bold">What is </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion?</span></p>
<p>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is a prescription medicine used to get rid of lice in scalp hair of children and adults.</p>
<p>It is not known if ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is safe for children under 6 months of age or in people over age 60.</p>
<p>Once ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is washed off, a fine-tooth comb may be used to remove treated lice and nits from the hair and scalp.  All personal items exposed to the hair or lice should be washed in hot water or dry-cleaned.  <span class="Bold">See â€œHow do I stop the spread of lice?â€? at the end of this leaflet.</span></p>
<p><span class="Bold">Â </span></p>
<p><span class="Bold">What should I tell </span><span class="Bold">my healthcare provider before I use </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion?</span></p>
<p>Tell your healthcare provider if your baby was born early so your healthcare provider can decide if your infant is old enough for ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</p>
<p><span class="Bold">Before you use </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"> Lotion</span><span class="Bold">, tell </span><span class="Bold">your healthcare provider if you:</span></p>
<ul class="Square">
<li>have any skin conditions or sensitivities<br>
</li>
<li>have any other medical conditions<br>
</li>
<li>are pregnant or plan to become pregnant.  It is not known if ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion can harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.Â <br>
</li>
<li>are breastfeeding.  It is not known if ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion passes into your breastÂ milk or if it can harm your baby.  You should choose to breastfeed or use ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion, but not both.  Talk to your healthcare provider about other ways to feed your baby while using ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</li>
</ul>
<p><span class="Bold">How should I use </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion</span><span class="Bold">?</span></p>
<ul class="Square">
<li>Use ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion exactly as prescribed.  Your healthcare provider will prescribe the treatment that is right for you.  Do not change your treatment unless you talk to your healthcare provider.<br>
</li>
<li>Use ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion in two applications that are one week apart.  ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion gets rid of lice but does not get rid of lice eggs so a second application is needed one week (7 days) after the first application. <br>
</li>
<li>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion coats the lice on your scalp and scalp hair.    It is important to use enough ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to coat completely every single louse and to leave it on your scalp for the full 10 minutes.  See the detailed Instructions for Use at the end of this leaflet.<br>
</li>
<li>Because you need to completely cover all of the lice with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion, you may need help in applying ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to your scalp and hair.  Make sure that you and anyone who helps you apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion reads and understands this leaflet and the Instructions for Use.<br>
</li>
<li>Children need adult help in applyingÂ ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.<br>
</li>
<li>Do not get into eyes.  If ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion gets in the eye, flush with water right away.<br>
</li>
<li>Do not swallow ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.  If swallowed, call your healthcare provider right away.<br>
</li>
<li>Wash your hands after you apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</li>
</ul>
<p><span class="Bold">What are the possible side effects of </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion? </span><span class="Bold">Â </span></p>
<p>People using ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion may have skin or eye:</p>
<ul class="Square">
<li><span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>,<br>
</li>
<li><span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>,<br>
</li>
<li>irritation.  If skin or <span class="product-label-link" type="condition" conceptid="4049206" conceptname="Burning sensation in eye">eye irritation</span> happens, rinse with water right away, then call your healthcare provider or go to the emergency department.</li>
</ul>
<p>Tell your healthcare provider if you have any side effect that bothers you or that does not go away.</p>
<p>These are not all the side effects of<span class="Bold">Â </span>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.  For more information, ask your healthcare provider or pharmacist.</p>
<p>Call your doctor for medical advice about side effects.  You may report side effects to FDA at 1-800-FDA-1088.</p>
<p><span class="Bold">How should I store </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion?</span></p>
<ul class="Square">
<li>Store ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion in a dry place at room temperature betweenÂ 68Â°F to 77Â°F (20Â°C to 25Â°C).<br>
</li>
<li>Do not freeze<span class="Bold">Â </span>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</li>
</ul>
<p><span class="Bold">Keep </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion and all medicines out of the reach of children.</span></p>
<p><span class="Bold">What are the ingredients in </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion?</span></p>
<p>Active ingredient: benzyl alcohol, 5%</p>
<p>Inactive ingredients:<span class="Bold">Â </span>purified water, mineral oil, sorbitan monooleate, polysorbate 80, carbomer 934P and trolamine</p>
<p><span class="Bold">General Information about </span><span class="Bold">ULESFIA</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold">Â </span><span class="Bold">Lotion </span></p>
<p>Medicines are sometimes prescribed for conditions other than those described in the Patient Information leaflet.  Do not useÂ ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion for any condition for which it was not prescribed by your healthcare provider.  Do not give ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to other people, even if they have the same symptoms as you.  It may harm them.</p>
<p>This leaflet summarizes the most important information about ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.  If you would like more information, talk to your healthcare provider.  You can also ask your healthcare provider for information about ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion that is written for healthcare professionals.  </p>
<p><span class="Bold">Instruction</span><span class="Bold">s</span><span class="Bold"> for </span><span class="Bold">U</span><span class="Bold">se</span></p>
<p>Apply the full amount of<span class="Bold">Â </span>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion prescribed by your healthcare provider for each of your 2Â applications one week apart.Â Â ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion gets rid of lice but does not get rid of lice eggs so a second application is needed one week (7 days) after the first application.</p>
<p>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion comes in a single 8 oz. bottle, and in a 2 pack containing two 8 oz. bottles with a lice comb. For different hair lengths, use the following as a guide for the amount of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion you may need to cover the hair and scalp completely:</p>
<table>
<col width="127">
<col width="180">
<tbody class="Headless">
<tr class="First">
<td class="Lrule Rrule Toprule" align="left" valign="bottom">Hair Length</td>
<td class="Lrule Rrule Toprule" align="left">Amount of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to apply each time</td>
</tr>
<tr>
<td class="Lrule Rrule" align="left"></td>
<td class="Lrule Rrule Toprule" align="left"><span class="Bold">8 oz. bottle</span></td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Short- up to 2 inches</td>
<td class="Lrule Rrule Toprule" align="left">up to Â¾ the bottle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Short- 2-4 inches</td>
<td class="Lrule Rrule Toprule" align="left">up to 1 bottle</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Medium- 4-8 inches</td>
<td class="Lrule Rrule Toprule" align="left">up to 1Â½ bottles</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Medium- 8-16 inches</td>
<td class="Lrule Rrule Toprule" align="left">up to 3 bottles</td>
</tr>
<tr>
<td class="Lrule Rrule Toprule" align="left">Long- 16-22 inches</td>
<td class="Lrule Rrule Toprule" align="left">up to 4 bottles</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule Toprule" align="left">Long- 22 inches or more</td>
<td class="Lrule Rrule Toprule" align="left">up to 6 bottles</td>
</tr>
</tbody>
</table>
<p><span class="Bold">Step 1</span></p>
<p><img alt="cover your face and eyes with a towel and keep your eyes closed tightly." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-02.jpg"></p>
<ul class="Square">
<li>Cover your face and eyes with a towel and keep your eyes closed tightly.<br>
</li>
<li>Apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion directly to <span class="Underline">dry</span>Â scalp and <span class="Underline">dry</span>Â hair.<br>
</li>
<li>ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion must cover your entire scalp and all scalp hair.  Have an adult help you apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</li>
</ul>
<p><span class="Bold">Step 2</span></p>
<p><img alt="massage Ulesfia Lotion into your hair and scalp." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-03.jpg"></p>
<ul class="Square">
<li>Massage ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion into your hair and scalp.<br>
</li>
<li>When your head is completely covered with enough ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion, dripping will happen.  Protect your eyes and skin from these drips with your towel. </li>
</ul>
<p><img alt="be sure to apply Ulesfia Lotion to the area behind your ears" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-04.jpg"></p>
<ul class="Square"><li>Be sure to apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to the area <span class="Underline">behind your ears</span><span class="Underline">.</span>Â </li></ul>
<p><img alt="Be sure to apply Ulesfia Lotion to the back of your neck." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-05.jpg"></p>
<ul class="Square"><li>Be sure to apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to the <span class="Underline">back of your neck</span>. </li></ul>
<p>If not enough ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion is used, some lice may escape treatment.  It is important to use the full amount of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion prescribed by your healthcare provider. </p>
<p><img alt="correct application of Ulesfia Lotion" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-06.jpg"></p>
<p>Correct application of ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</p>
<p><span class="Bold">Step 3</span></p>
<p><img alt="Allow Ulesfia Lotion to stay on your hair for 10 minutes. Use a timer or clock." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-07.jpg"></p>
<ul class="Square">
<li>Allow ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion to stay on your hair for 10 minutes.  Use a timer or clock. <br>
</li>
<li>Start timing after you have completely covered your hair and scalp with ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion.</li>
</ul>
<p>
		Â Â Â Â Â 
	</p>
<p><span class="Bold">Â </span><span class="Bold">Step 4</span></p>
<p><img alt="After 10 minutes, completely rinse Ulesfia Lotion from your hair and scalp with water." src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-08.jpg"></p>
<ul class="Square">
<li>After 10 minutes, completely rinse ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion from your hair and scalp with water.<br>
</li>
<li>You or anyone who helps you apply ULESFIA<span class="Bold"><span class="Sup">Â®</span></span>Â Lotion should wash your hands after application.<br>
</li>
<li>You can shampoo your hair right after the application.<br>
</li>
<li>A lice comb may be used to remove the dead lice after both applications.</li>
</ul>
<p><span class="Bold">Step 5 </span></p>
<p>One week (7 days) after your first application, repeat the steps above to help get rid of lice that hatched from eggs.</p>
<p><span class="Bold">How do I stop the spread of lice?</span></p>
<p>To help prevent the spread of lice from one person to another, here are some steps you can take. </p>
<ul class="Square">
<li>Avoid head-to-head contact at school, on the playground, in physical education classes, during sports activities, and while playing with other children. <br>
</li>
<li>Do not share combs, brushes, hats, scarves, bandannas, ribbons, barrettes, hair bands, towels, helmets, or other hair-related personal items with anyone else, whether they have lice or not.<br>
</li>
<li>Avoid sleepovers and slumber parties during lice outbreaks.  Lice can live in bedding, pillows, and carpets that have recently been used by someone with lice.<br>
</li>
<li>After finishing treatment with lice medicine, check everyone in your family for lice after one week.  Be sure to talk to your healthcare provider about treatments for those who have lice.<br>
</li>
<li>Machine-wash any bedding and clothing used by anyone having lice or thought to have been exposed to lice.  Machine wash at <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">high temperatures</span> (150Â°F) and tumble in a hot dryerÂ for 20 minutes.</li>
</ul>
<p>Â </p>
<p><span class="Bold">This Patient </span><span class="Bold">Information</span><span class="Bold"> has been approved by the U.S. Food and Drug Administration.</span></p>
<p>MANUFACTURED FOR:Â Â Â Â Â Â Â Â <br>Concordia Pharmaceuticals Inc.Â Â Â Â Â Â Â Â Â Â Â <br>Bridgetown, Barbados BB11128Â Â Â Â Â </p>
<p>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â </p>
<p>BY:
		Â Â Â Â Â 
	
		Â Â Â Â Â 
	Â Â Â Â Â Â Â Â <br>Contract Pharmaceuticals Limited<br>Mississauga, Ontario L5N 6L6<br>Canada</p>
<p><span class="Bold">Revised: </span><span class="Bold">09/2013</span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">PRINCIPAL DISPLAY PANEL</span></p>
<p><span class="Bold">NDC 59212-780-08 </span>Â Â Â Â Â  <span class="Bold">Â Â Â Â Â  Rx only</span><span class="Bold"><br>Ulesfia</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"><br>(benzyl alcohol)</span><span class="Bold"><br>Lotion, 5%</span><span class="Bold"><br>8 oz (227 g)</span><span class="Bold"><br>CONCORDIA PHARMACEUTICALS INC. </span></p>
<p><img alt="PRINCIPAL DISPLAY PANEL
NDC 59212-780-08 		Rx only
UlesfiaÂ®
(benzyl alcohol)
Lotion, 5%
8 oz (227 g)
CONCORDIA PHARMACEUTICALS INC.
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-09.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L9c69a6e7-e2e6-4770-a5c7-124607456cf3"></a><a name="section-18"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">NDC 59212-780-88 </span>Â Â Â Â Â  <span class="Bold">Â Â Â Â Â  Rx only</span><span class="Bold"><br>Ulesfia</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"><br>(benzyl alcohol)</span><span class="Bold"><br>Lotion, 5%</span><span class="Bold"><br>2-PACK</span><span class="Bold"><br>with lice comb</span><span class="Bold"><br>8 oz (227 g) per bottle</span><span class="Bold"><br>2 bottles in the carton</span><span class="Bold"><br>CONCORDIA PHARMACEUTICALS INC. </span></p>
<p><img alt="PRINCIPAL DISPLAY PANEL
NDC 59212-780-88 		Rx only
UlesfiaÂ®
(benzyl alcohol)
Lotion, 5%
2-PACK
with lice comb
8 oz (227 g) per bottle
2 bottles in the carton
CONCORDIA PHARMACEUTICALS INC. 
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aeba2488-1ac3-4c02-833c-78a36859f029&amp;name=ulesfia-10.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ULESFIAÂ 		
					</strong><br><span class="contentTableReg">benzyl alcohol lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:59212-780</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>BENZYL ALCOHOL</strong> (BENZYL ALCOHOL) </td>
<td class="formItem">BENZYL ALCOHOL</td>
<td class="formItem">50Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MINERAL OIL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBITAN MONOOLEATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYSORBATE 80</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TROLAMINE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">Â Â Â Â </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59212-780-88</td>
<td class="formItem">2  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">227 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:59212-780-08</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">227 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA022129</td>
<td class="formItem">05/26/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Concordia Pharmaceuticals Inc.
							(860243190)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 1/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>83c434a7-b6aa-4966-8d33-3c1bf676632f</div>
<div>Set id: aeba2488-1ac3-4c02-833c-78a36859f029</div>
<div>Version: 1</div>
<div>Effective Time: 20140121</div>
</div>
</div>Â <div class="DistributorName">Concordia Pharmaceuticals Inc.</div></p>
</body></html>
